Younossi Z et al. Positive Results from REGENERATE: A Phase 3 International, Randomized, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for NASH. (Abstract GS-06)
Effectiviteit en veiligheid van 104 weken subcutaan lenacapavir bij multiresistente hiv-1
jul 2025 | HIV, Virale infecties